Clinical Trials List
2020-12-01 - 2027-12-31
Phase II/III
Recruiting3
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yung-Hung Luo Division of Thoracic Medicine
- Chia-I Shen Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
- Yuh-Min Chen Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Heng-Sheng Chao 未分科
- Hsu-ching Huang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳正雄 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 林俊維 Division of Thoracic Medicine
- 葉金水 Division of Thoracic Medicine
- 張竣期 Division of Thoracic Medicine
- 黃國揚 Division of Thoracic Medicine
- 施穎銘 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
- 林慶雄 Division of Thoracic Medicine
- 林明泰 Division of Thoracic Medicine
- 詹博強 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Yen Tu Division of Thoracic Medicine
- 陳鴻仁 Division of Thoracic Medicine
- 廖偉志 Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10-30 participants
-
Global
540 participants
